In addition, treated cells reduced expression levels of Il7r, indicating pharmacological inhibition of IRE1α negatively impacting IL‐7R signalling through the loss of XBP1 splicing in pre‐B ALL cells (Figure 3A). Here, IL7R is linked to acute lymphoblastic leukemia.